Understanding the Intricacies of Pulmonary Arterial Hypertension

Activity Summary

Required reading for all learners: Implicit Bias impacts patient outcomes

Pulmonary hypertension (PH) is a progressive disorder that worsens slowly over time, potentially leading to cardiac and respiratory complication. It even can be fatal. Early identification and management can help to improve quality of life and prevent the progression of this debilitating disease. Nurses play a crucial role in symptom assessment, implementing treatment and educating patients and families on pulmonary hypertension medications.

Objectives

Define pulmonary hypertension (PH) and its five clinical subgroupings with their predisposing factors.
Explain the treatment guidelines for PH and specific safety measures with the administration of intravenous prostacyclin in PAH.
Describe the role of bedside nurses in managing, educating and counseling patients with PAH.

Continuing Education Disclosure Statement

Criteria for Awarding Contact Hours

Learners must complete the entire activity and the associated evaluation AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.

Accreditation

American Association of Critical-Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for {contactHours} contact hours.

Disclosures

The Nurse Planner has determined that no individuals with the ability to control content of this activity have relevant relationships with ineligible companies.

Activities with pharmacotherapeutic credit are to assist the APRN in fulfilling their education requirements for licensure and certification renewals.

Refund Policy

Continuing Education Activities are nonrefundable.